Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
92.32 | 9.38% | 22.91% | 188,370.32 | 3.57% | 4.67% |
|
SWX:ROG
Roche Holding
|
225.10 | 32.03% | 48.13% | 181,774.36 | 4.26% | 0.43% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.94 | 58.46% | 68.59% | 91,097.88 | 5.34% | 13.54% |
|
ENXTBR:ARGX
argenx
|
347.90 | 0% | 0% | 20,660.58 | 0% | 0% |
|
NasdaqGS:INCY
Incyte
|
53.06 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
50.80 | 18.28% | 30.99% | 10,363.08 | 2.36% | 10.99% |
|
CPSE:ZEAL
Zealand Pharma A/S
|
657.50 | 0% | 0% | 40,945.73 | 0% | 0% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.94 | 25.31% | 38.17% | 4,424.39 | 2.89% | 10.04% |
|
HLSE:ORNBV
Orion Oyj
|
37.68 | 22.61% | 65.62% | 5,117.58 | 4.3% | -0.43% |
|
CPSE:ALK B
ALK-Abelló A/S
|
153.30 | 48.16% | 94.21% | 33,908.31 | 0% | 171.44% |
|
LSE:INDV
Indivior PLC
|
14.32 | -23.61% | -1.68% | 1,952.43 | 0% | -2.7% |
|
BME:ALM
Almirall
|
9.16 | -40.61% | 37.83% | 1,794.5 | 2.07% | 2.38% |
|
NasdaqGM:XNCR
Xencor
|
22.48 | -,201.57% | -,154.65% | 1,498.65 | 0% | 0% |
|
SWX:COPN
Cosmo Pharmaceuticals N.V.
|
70.80 | -8.78% | 50.69% | 1,136.54 | 2.76% | -76.88% |
|
BME:FAE
Faes Farma
|
3.53 | 14.51% | 24.13% | 1,089.37 | 4.39% | 6.96% |
|
BME:PHM
Pharma Mar
|
33.30 | 0% | 0% | 536.95 | 1.95% | -39.63% |
|
SWX:BSLN
Basilea Pharmaceutica
|
42.95 | -15.89% | -17.77% | 474.13 | 0% | 0% |
|
ENXTPA:DBV
DBV Technologies
|
1.21 | 0% | 0% | 115.65 | 0% | 0% |
|
SWX:MOLN
Molecular Partners
|
3.24 | 0% | 0% | 110.77 | 0% | 0% |
|
NasdaqGS:KPTI
Karyopharm Therapeutics
|
1.09 | 0% | 0% | 118.8 | 0% | 0% |
